Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page
- Check7 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; no changes to the trial details or page content are visible.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2 on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no visible changes to study details, layout, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1, with no substantive changes to trial details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedA minor revision update from v3.3.3 to v3.3.4 is displayed on the page, with no observed changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page now includes a Locations section with North Carolina listed as a location. The old 'North Carolina Locations' entry and 'HHS Vulnerability Disclosure' link were removed, and the revision is updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.